Chen Hongming 4
4 · Kala Pharmaceuticals, Inc. · Filed Jun 29, 2020
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Award
Comman Stock
2020-06-25+16,000→ 102,849 total
Footnotes (2)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on June 25, 2021 and the remaining 50% of the shares underlying the RSUs on June 25, 2022.
- [F2]Includes 16,000 unvested RSUs.